Jianpi Huoxue Decoction Ameliorates Alcohol-associated Liver Disease by Improving Intestinal Barrier Function in Rats.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Huazhong University of Science and Technology Country of Publication: China NLM ID: 101729993 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2523-899X (Electronic) Linking ISSN: 2523899X NLM ISO Abbreviation: Curr Med Sci Subsets: MEDLINE
    • Publication Information:
      Original Publication: Wuhan : Huazhong University of Science and Technology, [2018]-
    • Subject Terms:
    • Abstract:
      Objective: Jianpi huoxue decoction (JHD), a Chinese herbal formula, is commonly used for treating alcohol-associated liver disease (ALD). This study aimed to investigate the mechanism by which JHD affects intestinal barrier function in ALD rats.
      Methods: The Sprague-Dawley rats were randomly divided into three groups: control group, model group and JHD group. They were pair-fed a modified Lieber-DeCarli liquid diet containing alcohol (model group, n=10; JHD group, n=10) or isocaloric maltose dextrin (control group, n=10) for 6 weeks. After 3 weeks of feeding, the mice in the JHD group were given JHD (10 mL/kg/day) by gavage for 3 weeks, and those in the control and model groups received equal amounts of double-distilled water for the same period of time. Afterwards, all the rats were given lipopolysaccharide (LPS) by gavage and sacrificed 3.5 h later. LPS levels were measured in the portal blood to evaluate gut leakage. Transmission electron microscopy (TEM) was used to observe ultrastructural changes in the intestinal tract. Adherens junction (AJ) and tight junction (TJ) proteins were detected by Western blotting, immunofluorescence or immunohistochemistry.
      Results: JHD ameliorated Lieber-DeCarli liquid diet-induced hepatic steatosis, inflammation and LPS expression. It improved pathological changes in the liver and alleviated intestinal ultrastructure injury. Moreover, it significantly enhanced the integrity of tight junctions by increasing the expression of zonula occludens-1 (ZO-1) and occludin. It suppressed the activation of myosin light chain (MLC) phosphorylation.
      Conclusion: JHD improves intestinal barrier function and reduces gut leakiness in ALD rats.
      Competing Interests: Conflict of Interest Statement. The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.
      (© 2024. Huazhong University of Science and Technology.)
    • References:
      Avila MA, Dufour JF, Gerbes AL, et al. Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting. Gut, 2020,69(4):764–780. (PMID: 10.1136/gutjnl-2019-31972031879281)
      Mackowiak B, Fu Y, Maccioni L, et al. Alcohol-associated liver disease. J Clin Invest, 2024,134(3):e176345. (PMID: 10.1172/JCI1763453829959110836812)
      Thursz M, Kamath PS, Mathurin P, et al. Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study. J Hepatol, 2019,70(3):521–530. (PMID: 10.1016/j.jhep.2018.10.04130658117)
      Bukong TN, Cho Y, Iracheta-Vellve A, et al. Abnormal neutrophil traps and impaired efferocytosis contribute to liver injury and sepsis severity after binge alcohol use. J Hepatol, 2018,69(5):1145–1154. (PMID: 10.1016/j.jhep.2018.07.005300301496310218)
      Ge X, Leung TM, Arriazu E, et al. Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-alpha and prevents early alcohol-induced liver injury in mice. Hepatology, 2014,59(4):1600–1616. (PMID: 10.1002/hep.2693124214181)
      Liang S, Zhong Z, Kim SY, et al. Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria. J Biol Chem, 2019,294(33):12359–12369. (PMID: 10.1074/jbc.RA119.007409312355226699832)
      Mathurin P, Deng QG, Keshavarzian A, et al. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology, 2000,32(5):1008–1017. (PMID: 10.1053/jhep.2000.1962111050051)
      Enomoto N, Ikejima K, Yamashina S, et al. Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin Exp Res, 2001,25(6 Suppl):51S–54S. (PMID: 10.1111/j.1530-0277.2001.tb02418.x11410742)
      Wang Y, Tong J, Chang B, et al. Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins. Mol Med Rep, 2014,9(6):2352–2356. (PMID: 10.3892/mmr.2014.212624718485)
      Purohit V, Bode JC, Bode C, et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol, 2008,42(5):349–361. (PMID: 10.1016/j.alcohol.2008.03.131185040852614138)
      Tang Y, Banan A, Forsyth CB, et al. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res, 2008,32(2):355–364. (PMID: 10.1111/j.1530-0277.2007.00584.x18162065)
      Van Spaendonk H, Ceuleers H, Witters L, et al. Regulation of intestinal permeability: The role of proteases. World J Gastroenterol, 2017,23(12):2106–2123. (PMID: 10.3748/wjg.v23.i12.2106284051395374123)
      Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci, 2013,70(4):631–659. (PMID: 10.1007/s00018-012-1070-x22782113)
      Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol, 2009,124(1):3–20. (PMID: 10.1016/j.jaci.2009.05.038195605754266989)
      Buckley A, Turner JR. Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease. Cold Spring Harb Perspect Biol, 2018,10(1):a029314. (PMID: 10.1101/cshperspect.a029314285070215749156)
      Keshavarzian A, Holmes EW, Patel M, et al. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol, 1999,94(1):200–207. (PMID: 10.1111/j.1572-0241.1999.00797.x9934756)
      Ulluwishewa D, Anderson RC, McNabb WC, et al. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr, 2011,141(5):769–776. (PMID: 10.3945/jn.110.13565721430248)
      Fang ZH, Hu YY, et al. Relationship between alcoholic liver injury and endotoxin leakage from gut and intervention effect of jianpi liqi huoxue decoction. Chin J Integ Med, 2006,26(9):813–817.
      Guo F, Zheng K, Benede-Ubieto R, et al. The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease. Alcohol Clin Exp Res, 2018,42(10):1828–1840. (PMID: 10.1111/acer.1384030025151)
      Yang X, He F, Zhang Y, et al. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mpsi Axis and Modulating Gut Microbiota in Mice. Alcohol Clin Exp Res, 2019,43(3):411–424. (PMID: 10.1111/acer.1395030589437)
      Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg, 1970,101(4):478–483. (PMID: 10.1001/archsurg.1970.013402800300095457245)
      Bataller R, Arab JP, Shah VH. Alcohol-Associated Hepatitis. N Engl J Med, 2022,387(26):2436–2448. (PMID: 10.1056/NEJMra220759936577100)
      Wu X, Fan X, Miyata T, et al. Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease. Annu Rev Pathol, 2023,18:411–438. (PMID: 10.1146/annurev-pathmechdis-031521-03043536270295)
      Peng JH, Hu YY, Cheng Y, et al. Effect of JIANPI HUOXUE decoction on inflammatory cytokine secretion pathway in rat liver with lipopolysaccharide challenge. World J Gastroenterol, 2008,14(12):1851–1857. (PMID: 10.3748/wjg.14.1851183506222700410)
      Cui J, Hu Y, Fang Z, et al. Intervention Effects of Jianpi Liqi Huoxue Decoction on Lipid Peroxidative Liver Injury Induced by Alcohol. Chin J Integr Med, 2006,12(4):281–286. (PMID: 10.1007/s11655-006-0281-017361525)
      Peng JH, Hu YY, Feng Q, et al. Effect of Jianpi Huoxue decoction-containing serum on tumor necrosis factor-alpha secretion and gene expression of endotoxin receptors in RAW264.7 cells induced by lipopolysaccharide. Chin J Integr Med, 2009,15(3):198–203. (PMID: 10.1007/s11655-009-9001-x19247585)
      Maccioni L, Gao B, Leclercq S, et al. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes, 2020,12(1):1782157. (PMID: 10.1080/19490976.2020.1782157325887257524402)
      Swanson GR, Garg K, Shaikh M, et al. Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease. Clin Transl Gastroenterol, 2024,15(4):e00689. (PMID: 10.14309/ctg.00000000000006893833495311042778)
      Camara-Lemarroy CR, Metz L, Meddings JB, et al. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain, 2018,141(7):1900–1916. (PMID: 10.1093/brain/awy131298603806022557)
      Angulo-Urarte A, van der Wal T, Huveneers S. Cell-cell junctions as sensors and transducers of mechanical forces. Biochim Biophys Acta Biomembr, 2020,1862(9):183316. (PMID: 10.1016/j.bbamem.2020.18331632360073)
      Adil MS, Narayanan SP, Somanath PR. Cell-cell junctions: structure and regulation in physiology and pathology. Tissue Barriers, 2021,9(1):1848212. (PMID: 10.1080/21688370.2020.184821233300427)
      Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol, 2004,36(7):1206–1237. (PMID: 10.1016/j.biocel.2003.08.00715109567)
      Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol, 2009,9(11):799–809. (PMID: 10.1038/nri265319855405)
      Shen Q, Rigor RR, Pivetti CD, et al. Myosin light chain kinase in microvascular endothelial barrier function. Cardiovascular Research, 2010,87(2):272–280. (PMID: 10.1093/cvr/cvq144204791302895546)
      Gandhi S, Lorimer DD, de Lanerolle P. Expression of a mutant myosin light chain that cannot be phosphorylated increases paracellular permeability. Am J Physiol, 1997,272 (2Pt2):F214–F221. (PMID: 9124398)
      Cunningham KE, Turner JR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci, 2012,1258(1):34–42. (PMID: 10.1111/j.1749-6632.2012.06526.x227317133384706)
      Clayburgh DR, Barrett TA, Tang Y, et al. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest, 2005,115(10):2702–2715. (PMID: 10.1172/JCI24970161841951224297)
      Shen L, Black ED, Witkowski ED, et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci, 2006,119 (Pt10):2095–2106. (PMID: 10.1242/jcs.0291516638813)
      Maccioni L, Fu Y, Horsmans Y, et al. Alcohol-associated bowel disease: new insights into pathogenesis. eGastroenterology, 2023,1(1):e100013. (PMID: 10.1136/egastro-2023-1000133766244910472976)
      Lang S, Schnabl B. Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. Cell Host Microbe, 2020,28(2):233–244. (PMID: 10.1016/j.chom.2020.07.007327911157467841)
    • Contributed Indexing:
      Keywords: Jianpi Huoxue decoction; alcohol-associated liver disease; intestinal barrier function; intestinal permeability; lipopolysaccharide; tight junction
    • Accession Number:
      0 (Drugs, Chinese Herbal)
      0 (Jianpi Huoxue decoction)
      0 (Zonula Occludens-1 Protein)
      0 (Lipopolysaccharides)
      0 (Occludin)
    • Publication Date:
      Date Created: 20241201 Date Completed: 20241223 Latest Revision: 20241223
    • Publication Date:
      20241223
    • Accession Number:
      10.1007/s11596-024-2955-2
    • Accession Number:
      39617866